Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort versus budesonide alone safety study in adult and adolescent asthma
2011-002790-28Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide and formoterol in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Time to first serious asthma-related event. Started Oct 2011; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-002790-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002790-28.